Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, July 25, 2022
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
Fri, July 22, 2022
[ Fri, Jul 22nd 2022
] - WOPRAI
[ Fri, Jul 22nd 2022
] - WOPRAI
[ Fri, Jul 22nd 2022
] - WOPRAI
[ Fri, Jul 22nd 2022
] - WOPRAI
[ Fri, Jul 22nd 2022
] - WOPRAI
[ Fri, Jul 22nd 2022
] - WOPRAI
[ Fri, Jul 22nd 2022
] - WOPRAI
[ Fri, Jul 22nd 2022
] - WOPRAI
[ Fri, Jul 22nd 2022
] - WOPRAI
[ Fri, Jul 22nd 2022
] - WOPRAI
[ Fri, Jul 22nd 2022
] - WOPRAI
[ Fri, Jul 22nd 2022
] - WOPRAI
[ Fri, Jul 22nd 2022
] - WOPRAI
[ Fri, Jul 22nd 2022
] - WOPRAI
Charles Duncan Initiated (BIVI) at Buy and Held Target at $70 on, Jul 22nd, 2022
Charles Duncan of Cantor Fitzgerald, Initiated "BioVie Inc." (BIVI) at Buy and Held Target at $70 on, Jul 22nd, 2022.
Charles, nor any peers, have made any analyst calls on BIVI in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30